- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
John C. Richter
Insights 24 results
Article · Source: U.S. Chamber of Commerce Litigation Center Blog
October 13, 2022
Top False Claims Act Developments
Client Alert
May 16, 2022
Cooperation Credit and Attorney-Client Privilege: The Implications of Coburn
Article
October 27, 2021
Congress Can Do Better Against Fraud
Feature
February 10, 2021
General Counsel Internal Investigations Decision Tree for the Automotive Industry
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry
Feature
January 15, 2021
General Counsel’s Decision Tree
Feature
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Life Sciences Industry
Article · Source: Law360
August 21, 2020
Pandemic Is No Excuse To Limit Defendants' Trial Rights
Client Alert
September 24, 2018
Echoes of the Brand Memo
Client Alert
January 31, 2018
The Brand Memorandum: DOJ Restricts Reliance on Agency Guidance in Civil Enforcement Actions
Client Alert
February 20, 2017
Global Investigations Review Conference Highlights the Future of Anti-Corruption Enforcement: Recapping GIR Live DC
Client Alert
November 1, 2016
FDA Launches Form for Reporting Allegations of Misconduct by Device Manufacturers